Cholecystokinin-B R/CCKBR: Small Molecules and Peptides
Cholecystokinin-B Receptor (CCKBR) is a G protein-coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. A misspliced transcript variant, including an intron, has been observed in cells from colorectal and pancreatic tumors.
6 results for "Cholecystokinin-B R/CCKBR Small Molecules and Peptides" in Products
6 results for "Cholecystokinin-B R/CCKBR Small Molecules and Peptides" in Products
Cholecystokinin-B R/CCKBR: Small Molecules and Peptides
Cholecystokinin-B Receptor (CCKBR) is a G protein-coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. A misspliced transcript variant, including an intron, has been observed in cells from colorectal and pancreatic tumors.
Selective CCK2 agonist
| Purity: | ≥95% (HPLC) |
CCK agonist
| Purity: | ≥95% (HPLC) |
Highly potent, selective non-peptide CCK2 antagonist
| Chemical Name: | (R)-N-[2,3-Dihydro-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)-urea |
| Purity: | ≥98% (HPLC) |
Selective CCK2 antagonist
| Chemical Name: | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea |
| Purity: | ≥98% (HPLC) |
Potent and selective CCK2 antagonist
| Alternate Names: | PD 134308 |
| Chemical Name: | 4-[[(1R)-2-[[(2R)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid |
| Purity: | ≥98% (HPLC) |
Selective CCK2 antagonist
| Chemical Name: | (4S,5R)-N-(4-Bromophenyl)-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide |
| Purity: | ≥98% (HPLC) |
